Amanote Research

Amanote Research

    RegisterSign In

Cabergoline Treatment in Acromegaly: Cons

Endocrine
doi 10.1007/s12020-014-0183-4
Full Text
Open PDF
Abstract

Available in full text

Date

February 7, 2014

Authors
Leandro KasukiLeonardo Vieira NetoMônica R. Gadelha
Publisher

Springer Science and Business Media LLC


Related search

Cabergoline Treatment in Acromegaly: Pros

Endocrine
2014English

Treatment Strategy for Acromegaly

Japanese Journal of Neurosurgery
SurgeryNeurology
2015English

Modern Treatment of Acromegaly

Postgraduate Medical Journal
Medicine
2003English

Acromegaly Pathogenesis and Treatment

Journal of Clinical Investigation
Medicine
2009English

Cabergoline in the Treatment of Hyperprolactinemia: A Study in 455 Patients

Obstetrical and Gynecological Survey
MedicineGynecologyObstetrics
2000English

Medical Treatment With Somatostatin Analogues in Acromegaly: Position Statement

The Korean Journal of Medicine
2019English

Correction: Changes in Glucose Tolerance After Treatment for Acromegaly

BMJ
1989English

Rhinorrhea After Cabergoline Treatment for Giant Invasive Macroprolactinoma: A Case Report

Turkish Journal of Endocrinology and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Cabergoline Treatment Rapidly Improves Gonadal Function in Hyperprolactinemic Males: A Comparison With Bromocriptine

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy